MedTrace Logo

LTR for Treatment of Obstructive Sleep Apnea

NCT03066765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-08-09

No results posted yet for this study

Summary

Study of tongue implant for treatment of obstructive sleep apnea

Conditions

Interventions

DEVICE

Linguaflex Tongue Retractor

Tongue implant

Sponsors & Collaborators

  • Linguaflex, Inc.

    lead INDUSTRY

Principal Investigators

  • Balwinder Singh, MD · Putrajaya Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-25
Primary Completion
2017-11-21
Completion
2018-02-05

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03066765 on ClinicalTrials.gov